Most workers who died of COVID-19 in 2020 were essential workers, study finds

Most working-age Americans who died of COVID-19 during the first year of the pandemic were so-called essential workers in labor, service and retail jobs that required on-site attendance and prolonged contact with others, according to a recently published study led by a University of South Florida epidemiologist.

The study looks back on COVID-19 deaths in 2020 and affirms what many had already known or suspected — that Americans who could not work from home and who labored in low-paying jobs with few or no benefits, such as paid sick leave and health insurance coverage, bore the brunt of deaths during the pandemic’s first year, said Jason Salemi, an associate professor in USF’s College of Public Health and co-author of the study.

Two cases of Omicron Covid variant identified in UK

The B.1.1.529 variant, described in Britain as ‘the most worrying we’ve seen’, was first found in southern Africa

The first cases of the new B.1.1.529 Covid-19 variant have been identified in the UK.

Two people found to be infected with the Omicron variant are self-isolating, according to the health secretary, Sajid Javid.

The two cases, which are connected, were identified in Chelmsford and Nottingham, Javid said. “The two individuals concerned are self-isolating alongside their whole household while further tests and sequencing is carried out, and contact tracing. The two cases are linked,” he said.

Continue reading

Dow tumbles 900 points for worst day of year on fears of new Covid variant, S&P 500 drops 2.53%

U.S. stocks dropped sharply on Friday as a new Covid variant found in South Africa triggered a global shift away from risk assets.

The Dow Jones Industrial Average dropped 905.04 points, or 2.53%, for its worst day of the year, closing at 34,899.34. The S&P 500 lost 2.27% to close at 4,594.62, while the Nasdaq Composite slipped 2.23% to finish at 15,491.66. The Dow was down more than 1,000 points at session lows.

FDA authorizes boosters for people 65+, high risk

The outside of the Food and Drug Administration headquarters is seen in White Oak, Md., on Monday, November 9, 2015. The FDA is a federal agency of the United States Department of Health and Human Services and has been in commission since 1906

The US Food and Drug Administration late Wednesday authorized booster doses of the Pfizer/BioNTech COVID-19 vaccine for people ages 65 and up. Also eligible for boosters will be those ages 18 to 64 who are at high risk of severe COVID-19 or at high risk from frequent occupational or institutional exposures to SARS-CoV-2, such as healthcare workers and teachers.

The single booster dose should only be given at least six months after the two initial doses. The authorization comes as an amendment to an Emergency Use Authorization.

Continue reading